Literature DB >> 18343506

Cholinergic modulation of midbrain dopaminergic systems.

J Mena-Segovia1, P Winn, J P Bolam.   

Abstract

Dopamine neurons in the midbrain respond to behavioral events and environmental stimuli. Their different patterns of activation in turn modulate the activity of forebrain regions and modulate the expression of selective behavioral responses. However, their activity is closely dependent on the cholinergic systems in the brainstem. Ascending cholinergic projections from the pedunculopontine and laterodorsal tegmental nuclei target dopaminergic neurons in the substantia nigra compacta and ventral tegmental area following a topographical gradient. These projections, by means of the activation of acetylcholine receptors, influence the firing of dopamine neurons and therefore their responsiveness, ultimately affecting the release of dopamine in their forebrain targets. Brainstem cholinergic neurons are thus in a position to critically influence the activity of dopaminergic neurons in the midbrain, and thereby have a critical role in the expression of behavior.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343506     DOI: 10.1016/j.brainresrev.2008.02.003

Source DB:  PubMed          Journal:  Brain Res Rev        ISSN: 0165-0173


  54 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

2.  Activity of neurochemically heterogeneous dopaminergic neurons in the substantia nigra during spontaneous and driven changes in brain state.

Authors:  Matthew T C Brown; Pablo Henny; J Paul Bolam; Peter J Magill
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

Review 3.  The ascending mesolimbic cholinergic system--a specific division of the reticular activating system involved in the initiation of negative emotional states.

Authors:  Stefan M Brudzynski
Journal:  J Mol Neurosci       Date:  2013-11-24       Impact factor: 3.444

Review 4.  Parallel basal ganglia circuits for voluntary and automatic behaviour to reach rewards.

Authors:  Hyoung F Kim; Okihide Hikosaka
Journal:  Brain       Date:  2015-05-16       Impact factor: 13.501

5.  Acetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity and neurotransmitter levels in the mesolimbic pathway.

Authors:  Lauren K Dobbs; Gregory P Mark
Journal:  Behav Brain Res       Date:  2011-09-17       Impact factor: 3.332

6.  Functional disconnection of the substantia nigra pars compacta from the pedunculopontine nucleus impairs learning of a conditioned avoidance task.

Authors:  Mariza Bortolanza; Evellyn C Wietzikoski; Suelen L Boschen; Patricia A Dombrowski; Mary Latimer; Duncan A A Maclaren; Philip Winn; Claudio Da Cunha
Journal:  Neurobiol Learn Mem       Date:  2010-06-01       Impact factor: 2.877

7.  M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's location.

Authors:  Daniel J Foster; Patrick R Gentry; Jose E Lizardi-Ortiz; Thomas M Bridges; Michael R Wood; Colleen M Niswender; David Sulzer; Craig W Lindsley; Zixiu Xiang; P Jeffrey Conn
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

Review 8.  Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms.

Authors:  H Morikawa; C A Paladini
Journal:  Neuroscience       Date:  2011-08-16       Impact factor: 3.590

Review 9.  Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

10.  Dual orexin actions on dorsal raphe and laterodorsal tegmentum neurons: noisy cation current activation and selective enhancement of Ca2+ transients mediated by L-type calcium channels.

Authors:  K A Kohlmeier; S Watanabe; C J Tyler; S Burlet; C S Leonard
Journal:  J Neurophysiol       Date:  2008-07-30       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.